Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
2.040
+0.080 (4.08%)
At close: Jun 5, 2026, 4:00 PM EDT
1.870
-0.170 (-8.33%)
After-hours: Jun 5, 2026, 7:56 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $48.13 million as of June 5, 2026. Its market cap has decreased by -38.75% in one year.
Market Cap
48.13M
Enterprise Value
24.00M
1-Year Change
-38.75%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $48.13M, a decrease of -76.95%. That is a compound annual growth rate of -27.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 48.13M | 37.84% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| aTyr Pharma | 50.30M |
| Metagenomi Therapeutics | 50.07M |
| Hyperion DeFi | 49.72M |
| Xilio Therapeutics | 49.72M |
| Estrella Immunopharma | 49.49M |
| Lantern Pharma | 48.17M |
| Radiopharm Theranostics | 48.08M |
| Actuate Therapeutics | 46.42M |